PALVELLA THERAPEUTICS INC (PVLA) Stock Balance Sheet
NASDAQ:PVLA - Nasdaq - US7207952026 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.36M | 17.40M | 38.63M | 117.76M | 70.44M | |||
| Marketable Securities | 0.00 | 8.97M | 20.53M | N/A | 0.00 | |||
| Receivables | 879.00K | 6.04M | 5.81M | 3.31M | 1.71M | |||
| Other Current Assets | 280.00K | 6.28M | 8.45M | 6.55M | 3.58M | |||
| Total Current Assets | 20.52M | 38.68M | 73.42M | 127.63M | 75.72M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | 0.00 | 20.70M | 23.03M | 25.98M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | 0.00 | 1.37M | 2.90M | 3.31M | |||
| Total Non-Current Assets | 0.00 | 0.00 | 22.07M | 25.93M | 29.29M | |||
| TOTAL ASSETS | 20.52M | 38.68M | 95.49M | 153.56M | 105.01M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 2.42M | 8.19M | 11.12M | 14.83M | 7.50M | |||
| Accounts Payable | 801.00K | 3.37M | 4.15M | 8.61M | 1.79M | |||
| Other Current Liabilities | 1.03M | 363.00K | 21.31M | 27.12M | 12.86M | |||
| Total Current Liabilities | 4.25M | 11.92M | 36.58M | 50.56M | 22.14M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 30.98M | 52.24M | 51.84M | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 30.98M | 52.24M | 51.84M | |||
| TOTAL LIABILITIES | 4.25M | 11.92M | 67.56M | 102.81M | 73.98M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -326.33M | -314.96M | -290.42M | -257.14M | -211.41M | |||
| Additional Paid In Capital | 342.92M | 341.60M | 318.53M | 307.00M | 242.67M | |||
| Common Shares | 1.00K | 98.00K | 74.00K | 72.00K | 56.00K | |||
| Other Shareholders' Equity | -316.00K | 28.00K | -254.00K | 829.00K | -295.00K | |||
| Shares Outstanding | 1.32M | 1.24M | 931.00K | 903.00K | 700.00K | |||
| Tangible Book Value per Share | 12.32 | 21.63 | 30.00 | 56.21 | 44.32 | |||
| Total Shareholders' Equity | 16.27M | 26.76M | 27.93M | 50.76M | 31.03M | |||
| TOTAL LIABILITIES AND EQUITY | 20.52M | 38.68M | 95.49M | 153.56M | 105.01M | |||
| Statistics | ||||||||
| Current Ratio | 4.82 | 3.24 | 2.01 | 2.52 | 3.42 | |||
| Return On Assets (ROA) | -77.74% | -63.45% | -34.85% | -29.79% | -35.45% | |||
| Return On Equity (ROE) | -98.06% | -91.72% | -119.15% | -90.12% | -119.99% | |||
All data in USD , ROIC based on taxRate of 0.21